Facebook
X
LinkedIn
ForwardAcute and Chronic Leukemias: Practical Applications 2026
This course offers Live (in-person) and Livestream (virtual) options.
October 9 - 10, 2026 - ARIA Resort & Casino - Las Vegas, Nevada
Course Directors: James M. Foran, M.D., Kebede H. Begna, M.D., and Jeanne M. Palmer, M.D.
This two-day comprehensive symposium reviews advances in bone marrow failure syndromes and hematologic malignancies. Participants will apply molecular risk stratification, optimize treatment strategies in MDS, AML, ALL, and MPNs, and integrate MRD, CHIP, and transplant considerations to improve patient-centered care.
Call for Abstracts
As part of the Mayo Clinic Acute and Chronic Leukemias: Practical Applications 2026 course, you are invited to submit an abstract for a poster presentation. Abstracts can be submitted using this form.
Submission Criteria
• Medical students, residents, fellows, staff, and other cancer care providers may apply
• Create a profile if you have not done so already, then log into your account.
• Complete and submit the abstract form no later than August 3, 2026
• Abstracts are limited to 250 words.
• Abstracts will be evaluated based on the quality of the abstract, relevance to the conference.
Notification of Results:
All primary authors will be notified by August 24, 2026, if their submission has been selected.
Presentation of Abstracts:
Abstracts chosen for presentation will be presented during the Mayo Clinic Acute and Chronic Leukemias: Practical Applications 2026 course held October 9-10, 2026, at the ARIA Hotel & Casino, Las Vegas, Nevada. All abstracts chosen for presentation will need to be provided in BOTH digital and poster format. The maximum dimensions of the poster can be 36 inches tall by 48 inches wide. For questions, please contact Jessica Sorensen at Sorensen.Jessica@mayo.edu
| Live Session | Fee |
|---|---|
| M.D., D.O., Ph.D. | $800 |
| Allied Health, NP, PA | $675 |
| Livestream Session | Fee |
|---|---|
| M.D., D.O., Ph.D. | $550 |
| Allied Health, NP, PA | $550 |
Target Audience
This course is designed for MDs, residents, fellows, nurses, physician assistants, and pharmacists.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Recognize the clinical, laboratory, and molecular features of bone marrow failure syndromes and distinguish among major diagnostic entities
- Apply risk stratification tools and molecular data (including TP53 status) to guide treatment selection in myelodysplastic syndromes
- Select appropriate therapeutic strategies for MDS and AML across disease stages, including management after hypomethylating agent failure and in relapsed/refractory AML
- Evaluate induction approaches and emerging therapies in acute leukemias, incorporating patient-specific and disease-specific factors
- Compare treatment approaches in ALL, including chemo-free regimens, allogeneic transplant, and CAR-T therapy, and integrate pediatric-informed strategies into adult care
- Manage myeloproliferative neoplasms using evidence-based therapies, including treatment selection in polycythemia vera, myelofibrosis, and TKI intolerance in CML
- Integrate molecular testing, minimal residual disease (MRD) assessment, and recognition of CHIP/CCUS into clinical practice, and manage key complications of allogeneic transplantation
Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.
Acute and Chronic Leukemias: Practical Applications 2026 | ||
ARIA Hotel & Casino, Las Vegas, Nevada | ||
October 9-10, 2026 | ||
Day 1 | Friday, October 9, 2026 | |
10:30 AM | Registration and Exhibits | |
11:00 AM | Welcome Announcements | |
11:15 AM | Plenary Presentation: Recognizing Adults BM Failure Syndromes Abhishek A. Mangaonkar, M.B.B.S. | |
12:00 PM | Lunch and Exhibits | |
12:00 PM | Optional Product Theater: Company 1 (no CME credit) Location: Joshua 1 | |
Session I: MDS & TP53 Moderator: James M. Foran, M.D. | ||
1:00 PM | Transplant-Eligibility in MDS Nandita Khera, M.D., M.P.H. | |
1:30 PM | Goals and Choices in low-grade MDS | |
2:00 PM | What do you do after HMA’s fail? Aref Al-Kali, M.D. | |
2:30 PM | Case: MDS with TP53 Mutations Case Presenter: Cecilia Y. Arana Yi, M.D. Panel: Aref Al-Kali, M.D., Talha Badar, M.B.B.S., M.D., Lisa Z. Sproat, M.D., Nandita Khera, M.D., M.P.H. | |
3:15 PM | Q&A Session Presenters | |
3:30 PM | PM Break | |
Session II: AML Moderator: Kebede H. Begna, M.D. | ||
3:45 PM | Complete Remission in AML - Does it matter how we get there? Antoine N. Saliba, M.D. | |
4:15 PM | Are we making progress in relapsed AML? TBC | |
4:45 PM | Case: Coordinating Care of AML in the Community Case Presenter: James M. Foran, M.D. Panel: Talha Badar, M.B.B.S., M.D., Antoine N. Saliba, M.D., Cecilia Y. Arana Yi, M.D., Emily M. Dyal, APRN, AGACNP-BC, M.S.N., Lucy M. Holmes, APRN, C.N.P., M.S.N., Katie M. Hanratty, APRN, M.S.N. | |
5:30 PM | Abstract Presentations Moderator: Kebede H. Begna, M.D. | |
6:00 PM | Welcome Reception Location: | |
|
| |
Day 2 | Saturday, October 10, 2026 | |
6:15 AM | Breakfast & Exhibits | |
6:30 AM | Optional Product Theater: Company 2 (no CME credit) Location: Joshua 1 | |
Session III: ALL Moderator: Kebede H. Begna, M.D. | ||
7:30 AM | Chemo-Free treatment for ALL (Ph+ & Ph-neg) Talha Badar, M.B.B.S., M.D. | |
8:00 AM | Evolving (Diminishing?) Role of Transplant Referral vs CAR-T for ALL | |
8:30 AM | Lessons from Pediatrics ALL | |
9:00 AM | AYA Case Presentation – Complex Care Coordination Case Presenter: Antoine N. Saliba, M.D., Panel: Madeleine B. O'Keefe, M.D., Talha Badar, M.B.B.S., M.D., Kristen B. McCullough, Pharm.D., R.Ph., MSML, BCOP, Nicole A. Gannon, P.A.-C., Lori J. DeCook, P.A.-C., M.S., Lucy M. Holmes, APRN, C.N.P., M.S.N. | |
9:45 AM | Q&A Session Presenters | |
10:00 AM | Refreshment Break and Exhibits
| |
Session IV: MPN Moderator: Jeanne M. Palmer, M.D. | ||
10:15 AM | Mast Cell & Eosinophilic Neoplasms | |
10:45 AM | Beyond hydroxyurea - new agents in P. vera, and when to incorporate them | |
11:15 AM | MF in 2026 – new agents and new strategies Naseema Gangat, M.B.B.S. | |
11:45 | TKI intolerance in CML: hold, reduce or switch? Kristen B. McCullough, Pharm.D., R.Ph., MSML, BCOP | |
12:15 AM | Q&A Session Presenters | |
12:30 PM | Lunch and Exhibits | |
12:30 PM | Optional Product Theater: Company 3 (no CME credit) Location: Joshua 1 | |
Session V: MRD, CHIP & Transplant Moderator: Jeanne M. Palmer, M.D. | ||
1:30 PM | A practical guide to molecular testing in myeloid malignancy Jennifer Jiang, M.D. and Emily Wolf, M.D. | |
2:00 PM | Case: MRD Testing in Acute leukemia (myeloid vs Lymphoid) Case Presenter: James M. Foran, M.D. Panel: Talha Badar, M.B.B.S., M.D.; Cecilia Y. Arana Yi, M.D., Jennifer Jiang, M.D., Dragan Jevremovic, M.D., Ph.D. | |
2:30 PM | How to Identify and manage CHIP & CCUS in 2026 | |
3:00 PM | Recognising late AlloBMT complications: chronic GVHD, TA-TMA, & HLH TBC | |
3:30 PM | Q&A Session Presenters | |
3:45 PM | Closing Remarks/Adjourn | |
All travel and lodging expenses are the sole responsibility of the individual registrant.
Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 12.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAPA
Mayo Clinic College of Medicine and Science has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 12.50 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
ANCC
Mayo Clinic College of Medicine and Science designates this activity for a maximum of 12.50 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Other Healthcare Professionals
A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.
| Day | Credits |
| Friday | 5.50 |
| Saturday | 7.00 |
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
Available Credit
- 12.50 AAPA Category 1
- 12.50 AMA PRA Category 1 Credit™
- 12.50 ANCC
- 12.50 Attendance
Thank you for your interest in Acute and Chronic Leukemias: Practical Applications 2026. This course is currently in the early planning stages. If you’d like to be notified when opportunities become available, please add your name to our Notify Me list. Signing up to be notified will ensure that you receive an email when exhibitor information is available. No additional information is available until then.
Please update your profile to let us know if you have dietary restrictions or access requirements.
To claim credit for livestream participation in this course, learners must view the content during the hours posted for the live activity. This course is not approved for on-demand delivery.
Commitment to Belonging and Inclusion
Mayo Clinic School of Continuous Professional Development (MCSCPD) strives to foster a learning environment in which all individuals are valued, allowing all to achieve their fullest potential.
Every effort will be made to accommodate dietary requirements; however, some requests may not be feasible based on venue kitchen capabilities. Attendees will be contacted in advance if a dietary restriction cannot be fulfilled.
The Mayo Clinic School of Continuous Professional Development strives for fully accessible learning experiences. If you anticipate any barriers while attending this course, please reach out to the course coordinator who will be in touch with all registrants. If you need disability-related accommodations, please contact the Office of Wellness and Academic Support – Disability Access Services at MCCMS.DS@mayo.edu.
Cancellation and Refund Policy
View Cancellation and Refund Policy
All requests must be submitted in writing using the Contact Us Form.
Any use of this site constitutes your agreement to the Terms and Conditions of Registration.